– Interview with David Galas, Ph.D., Senior Vice President of Strategic Partnerships, Institute for Systems Biology

Previous articleAvigen Implores Shareholders to Steer Clear of BVF’s Attempts to Gain Control of the Company
Next articleResearchers Discover Gene Variations that Protect against Cervical Cancer